DM
Deerfield Management Portfolio holdings
AUM
$7.8B
1-Year Est. Return
76.63%
This Fund
S&P 500
1 Year Est. Return
+76.63%
AUM
$7.8B
AUM Growth
+$1.28B
(+20%)
Holding
184
Top Buys
| 1 | +$85.1M | |
| 2 | +$80.6M | |
| 3 | +$63M | |
| 4 |
Stoke Therapeutics
STOK
|
+$54.8M |
| 5 |
Lantheus
LNTH
|
+$48.2M |
Top Sells
| 1 | +$287M | |
| 2 | +$110M | |
| 3 | +$105M | |
| 4 |
Centene
CNC
|
+$97.3M |
| 5 |
Merck
MRK
|
+$86.4M |
Sector Composition
| 1 | Healthcare | 87.23% |
| 2 | Real Estate | 0.35% |
| 3 | Financials | 0.06% |
| 4 | Consumer Discretionary | 0.04% |
| 5 | Consumer Staples | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$7.87B
| $1.74B | 22.24% |
17,248,450
-742,574
|
|
||
2
Cogent Biosciences
COGT
$6.31B
| $321M | 4.12% |
9,043,903
-9,215
|
|
||
3
Praxis Precision Medicines
PRAX
$9.17B
| $266M | 3.41% |
903,351
+62,500
|
|
||
|
4
Centene
CNC
$21.9B
| $265M | 3.4% |
6,447,998
-2,598,002
|
|
||
5
Viatris
VTRS
$18.1B
| $252M | 3.22% |
20,206,170
-3,892,913
|
|
||
6
Revolution Medicines
RVMD
$19.6B
| $231M | 2.96% |
2,894,613
-755,729
|
|
||
7
United Therapeutics
UTHR
$22.1B
| $208M | 2.66% |
425,993
|
|
||
8
Vera Therapeutics
VERA
$2.87B
| $206M | 2.64% |
4,059,695
+418,538
|
|
||
9
Celcuity
CELC
$5.01B
| $171M | 2.19% |
1,714,000
+980,470
|
|
||
10
Neurocrine Biosciences
NBIX
$13.3B
| $168M | 2.15% |
1,184,345
|
|
||
11
Ionis Pharmaceuticals
IONS
$13.3B
| $157M | 2.01% |
1,979,669
|
|
||
12
NewAmsterdam Pharma
NAMS
$3.77B
| $146M | 1.87% |
4,164,789
-101,904
|
|
||
13
Inspire Medical Systems
INSP
$1.85B
| $139M | 1.78% |
1,505,872
+458,178
|
|
||
14
Legend Biotech
LEGN
$3.41B
| $129M | 1.65% |
5,932,000
+2,969,662
|
|
||
15
Brookdale Senior Living
BKD
$3.6B
| $126M | 1.61% |
11,637,032
-4,610
|
|
||
16
Indivior Pharmaceuticals
INDV
$4B
| $122M | 1.56% |
3,393,063
-3,593,748
|
|
||
17
Arrowhead Research
ARWR
$9.01B
| $122M | 1.56% |
1,832,946
+839,946
|
|
||
18
Larimar Therapeutics
LRMR
$435M
| $117M | 1.49% |
30,606,974
|
|
||
19
Catalyst Pharmaceutical
CPRX
$2.94B
| $115M | 1.47% |
4,911,161
-63,606
|
|
||
20
AdaptHealth
AHCO
$1.31B
| $114M | 1.47% |
11,477,730
|
|
||
21
BioCryst Pharmaceuticals
BCRX
$2.14B
| $112M | 1.43% |
14,341,000
+2,172,000
|
|
||
22
ARS Pharmaceuticals
SPRY
$906M
| $87.4M | 1.12% |
7,503,812
|
|
||
23
Pharvaris
PHVS
$1.82B
| $86.7M | 1.11% |
3,126,042
+683,578
|
|
||
24
Savara
SVRA
$1.22B
| $81.8M | 1.05% |
13,569,000
+5,605,000
|
|
||
25
IDEAYA Biosciences
IDYA
$2.9B
| $74.4M | 0.95% |
2,153,043
|
|